# Adversary Tournament Findings — Barrier 1 Synthesis (Iteration 3)

> **Deliverable:** Barrier 1 Cross-Pollination Synthesis: Negative Prompting in LLMs (Revision 3)
> **File:** `projects/PROJ-014-negative-prompting-research/orchestration/neg-prompting-20260227-001/barrier-1/synthesis.md`
> **Criticality:** C4 (Critical)
> **Executed:** 2026-02-27
> **Agent:** adv-executor
> **Strategies:** S-010, S-003, S-002, S-004, S-001, S-007, S-011, S-012, S-013, S-014 (all 10, tournament mode)
> **H-16 Compliance:** VERIFIED — S-003 (Order 2) precedes S-002 (Order 3) per adversary-selection.md
> **Prior Iteration Score:** 0.90 (REVISE) — 14 Major + 14 Minor findings from I2
> **Score Trajectory:** I1=0.83 → I2=0.90 → I3=?

---

## Document Sections

| Section | Purpose |
|---------|---------|
| [Prior Finding Resolution Status](#prior-finding-resolution-status) | Explicit RESOLVED/PERSISTS for each I2 Major finding |
| [Tournament Summary Table](#tournament-summary-table) | One-line verdict per strategy |
| [S-010: Self-Refine Findings](#s-010-self-refine-findings) | Internal consistency and completeness self-review |
| [S-003: Steelman Findings](#s-003-steelman-findings) | Strongest-form reconstruction before critique |
| [S-002: Devil's Advocate Findings](#s-002-devils-advocate-findings) | Assumption challenge and logical probing |
| [S-004: Pre-Mortem Findings](#s-004-pre-mortem-findings) | Projected failure modes |
| [S-001: Red Team Findings](#s-001-red-team-findings) | Adversarial vulnerability probing |
| [S-007: Constitutional AI Findings](#s-007-constitutional-ai-findings) | Governance and P-rule compliance |
| [S-011: Chain-of-Verification Findings](#s-011-chain-of-verification-findings) | Source traceability audit |
| [S-012: FMEA Findings](#s-012-fmea-findings) | Risk quantification |
| [S-013: Inversion Findings](#s-013-inversion-findings) | Assumption robustness under inversion |
| [S-014: LLM-as-Judge Scoring](#s-014-llm-as-judge-scoring) | Final quality gate scoring |
| [Consolidated Findings Index](#consolidated-findings-index) | All new findings across all strategies |
| [Revision Priorities](#revision-priorities) | Ordered action list for I4 if required |

---

## Prior Finding Resolution Status

> For each Major finding from I2, explicit RESOLVED or PERSISTS verdict with evidence from R3.

### P1 Cluster (SR-002-R2 / CC-001-R2 / FM-010): Source count inconsistency (75 vs. 74)

**I2 Issue:** L0 stated 75 sources but Evidence Tier Analysis stated 74. The R2 addition of A-31 created a new internal inconsistency.

**R3 Change:** Evidence Tier Analysis section now reads: "**Total: 75 sources** (13 Tier 1 + 5 Tier 2 + 14 Tier 3 + 43 Tier 4 = 75). Tier 1 constitutes 17.3% of all sources. Tier 4 constitutes 57.3%." The Tier 3 count note explicitly states: "A-31 (Bsharat et al., arXiv:2312.16171) was added as a new source in R2 — it is a distinct document from I-13 (PromptHub, a secondary-citation industry blog)... The Tier 3 count increased from 13 (R2) to 14 (R3)." The Source Count Verification section now clarifies: "A-31 (Bsharat et al., arXiv:2312.16171) is a genuinely new source added in Revision 2... There is no replacement."

**Arithmetic verification:** 13 + 5 + 14 + 43 = 75. ✓ L0 states 75. ✓ Body states 75. ✓

**Verdict: RESOLVED** — The inconsistency is corrected. All three locations (L0, Tier Analysis, Source Count Verification) now state 75. The "A-31 replaces I-13" language is removed. The arithmetic is internally consistent.

---

### P2 Cluster (SR-001-R2 / CV-001-R2 / FM-011): Group C 4 unidentified sources

**I2 Issue:** The Group C arithmetic trace named only 9 sources explicitly plus "4 additional" that were not enumerated, preventing independent verification of the 75-source total.

**R3 Change:** The Source Count Verification section now contains a complete explicit table listing all 13 Group C unique sources by ID: C-2, C-3, C-6, C-7, C-8, C-9, C-10, C-11, C-12, C-13, C-14, C-19, C-20 — each with source title, context7 reference number, and notes explaining deduplication decisions. The Group C catalog in the source catalog also now marks all 13 with "COUNTED" status including previously unnamed entries C-2, C-3, C-12, and C-14. The finding "All 13 Group C unique sources are now explicitly named with IDs" appears in the R3 note at line 177.

**Verdict: RESOLVED** — All 13 Group C sources are now individually named, verifiable, and traced. A peer reviewer can independently verify the count.

---

### P3 (RT-001-R2): Publication bias not acknowledged in Known Scope Exclusions

**I2 Issue:** The Known Scope Exclusions section addressed production deployments (SE-1), domain-specific applications (SE-2), internal vendor benchmarks (SE-3), and grey literature (SE-4) but omitted publication bias (the "file drawer problem" in academic venue indexing), which is a standard systematic review limitation.

**R3 Change:** SE-5 has been added to Known Scope Exclusions: "SE-5: Publication Bias in Academic Venue Indexing. Academic search preferentially indexes published results. Studies demonstrating effective negative prompting techniques may have been conducted and submitted to academic venues but not accepted for publication... This synthesis cannot quantify the extent of this bias. The null finding on the 60% hypothesis may partially reflect publication patterns rather than a complete absence of positive evidence."

**Verdict: RESOLVED** — SE-5 is present and accurate. It correctly references the Cochrane Handbook and PRISMA guidelines and appropriately bounds what the null finding means.

---

### P4 (IN-001-R2 / CV-002-R2): Cond-6 epistemological flagging

**I2 Issue:** Cond-6 (Declarative behavioral negation) was derived from a synthesis-generated hypothesis (THEME-1) rather than from primary source evidence, but its derivation cell understated this epistemological weakness.

**R3 Change:** The Cond-6 entry in the Phase 2 Experimental Design table now reads: "THEME-1: synthesis-generated hypothesis (vendor practice pattern; testability noted). **[Synthesis-generated hypothesis — not directly sourced from primary evidence. This condition tests a synthesizer-observed pattern, not a source-supported finding. Phase 2 testing of Cond-6 is exploratory. Negative results should not be interpreted as invalidating the synthesis. Derivation chain from source to finding is incomplete for this condition.]**"

**Verdict: RESOLVED** — The epistemological status of Cond-6 is now explicitly labeled. The note is appropriately prominent (bold, bracketed), distinguishes exploratory testing from hypothesis confirmation, and prevents misinterpretation of negative results.

---

### P5 (SM-001-R2 / PM-001-R2 / FM-012): No relative priority between Cond-6 and Cond-7

**I2 Issue:** Both Cond-6 and Cond-7 were labeled "Recommended" with no relative ordering signal, despite Cond-7 (Tier 1, A-15, DeCRIM, two-benchmark replication) having substantially stronger evidence than Cond-6 (Tier 4, synthesis hypothesis).

**R3 Change:** The Phase 2 conditions table now uses "Recommended-A" and "Recommended-B" labels:
- Cond-7: "Recommended-A (higher priority within Recommended tier; implement before Cond-6 if resource-constrained)"
- Cond-6: "Recommended-B (lower priority within Recommended tier; if only one Recommended condition can be implemented, prioritize Cond-7)"
The PS Integration key finding #4 also now reads "plus 2 Recommended — Cond-7 (atomic decomposition, Recommended-A, Tier 1 evidence), Cond-6 (declarative behavioral negation, Recommended-B, synthesis hypothesis)."

**Verdict: RESOLVED** — The relative priority is now explicit and evidence-justified. A resource-constrained practitioner receives clear guidance.

---

### P6 (DA-002-R2): Alternative hypothesis placement creating anchoring risk

**I2 Issue:** The "On the revised hypothesis" paragraph appeared in L0 before the Phase 2 mandate, risking anchoring Phase 2 analysts to a synthesis-generated secondary claim before the primary null finding had been fully absorbed.

**R3 Change:** The alternative hypothesis paragraph has been renamed "Research direction from synthesis (secondary)" and moved to the end of L0, explicitly after the Phase 2 mandate paragraph. The paragraph itself now contains: "This hypothesis is positioned at the end of L0 to prevent anchoring Phase 2 analysts to a synthesis-generated secondary claim before the primary null finding and Phase 2 mandate have been absorbed (DA-002-R2 fix)."

**Verdict: RESOLVED** — The structural fix is implemented and accompanied by explicit rationale explaining why the placement matters. The Phase 2 mandate now precedes the alternative hypothesis.

---

### P7 (RT-002-R2 / DA-004-R2): AGREE-5 scope delineation

**I2 Issue:** AGREE-5 effectiveness hierarchy presented CAST (model-internal) and Constitutional AI (training-time) as top-ranked techniques in a hierarchy alongside prompt-engineering-accessible techniques, without an explicit scope delineation preventing misleading cross-level comparisons.

**R3 Change:** AGREE-5 now includes a prominent header note: "**IMPORTANT — Scope of comparison (RT-002-R2/DA-004-R2 fix):** Ranks 1–4 are NOT alternatives to prompt engineering; they operate at entirely different system layers (model-internal or training-time) with fundamentally different access requirements, cost structures, and use cases. A prompt engineer cannot implement ranks 1–4. The primary comparison relevant to PROJ-014 is within **ranks 5–12 (the prompt-engineering-accessible range)**. Do not compare ranks 1–4 against ranks 5–12 as if they were competing approaches at the same level."

**Verdict: RESOLVED** — The scope delineation is explicit, prominent, and prevents the misleading comparison attack documented in I2.

---

### P8 (SR-005-R2): PS Integration condition count mismatch

**I2 Issue:** PS Integration key finding #4 referenced "minimum 5 conditions (Cond-1 through Cond-5)" while the Phase 2 Design section documented 7 conditions (Cond-1 through Cond-7).

**R3 Change:** PS Integration key finding #4 now reads: "Phase 2 should test 7 conditions: 5 Required — Cond-1 (standalone negative), Cond-2 (standalone positive), Cond-3 (paired negative+positive), Cond-4 (justified negative+reason), Cond-5 (warning-based meta-prompt); plus 2 Recommended — Cond-7 (atomic decomposition, Recommended-A, Tier 1 evidence), Cond-6 (declarative behavioral negation, Recommended-B, synthesis hypothesis); see [Phase 2 Experimental Design Requirements] for full condition derivations and priority labels."

**Verdict: RESOLVED** — The PS Integration now accurately reflects all 7 conditions with explicit priority labels.

---

### P9 (DA-001-R2): Vendor product positioning bias not addressed in AGREE-3

**I2 Issue:** AGREE-3 acknowledged SE-3 (internal vendor benchmarks) but did not address the adversarial reading that vendor models are trained against their own test suites, making "use positive framing" potentially a circular optimization recommendation rather than a universal finding.

**R3 Change:** AGREE-3 now includes a dedicated "Caveat on vendor neutrality (DA-001-R2 fix)" paragraph: "Vendor recommendations for positive framing should be interpreted with an additional consideration: vendor models are fine-tuned and optimized against their own test suites and prompting guidance. The recommendation 'use positive framing' may partially reflect that these specific models are better-tuned to respond to positive framing through their training regimes — rather than a universal property of all LLMs or all model architectures. This would be a form of circular optimization: recommending what their own models were optimized to follow."

**Verdict: RESOLVED** — The circular optimization concern is explicitly addressed, and PROJ-014's multi-model testing is correctly identified as the mechanism to test whether the advantage is vendor-specific or universal.

---

### P10 (SR-003-R2): CONFLICT-4 section heading unqualified

**I2 Issue:** CONFLICT-4 section heading read "UNRESOLVED" without qualification, while the body note explained the UNRESOLVED label applied only to the natural-language self-refinement question. Heading-only readers received a misleading signal.

**R3 Change:** The CONFLICT-4 section heading now reads: "Does Self-Refinement Improve Negative Instruction Compliance Meaningfully? [UNRESOLVED — natural-language self-refinement question only; see note]"

**Verdict: RESOLVED** — The heading qualification prevents misleading scanning behavior. The scope of the UNRESOLVED label is now immediately visible.

---

### Minor I2 Findings Resolution Summary

| I2 Minor ID | Finding | Status |
|-------------|---------|--------|
| SR-003-R2 | CONFLICT-4 heading unqualified | RESOLVED (P10) |
| SR-004-R2 | No relative priority Cond-6/Cond-7 | RESOLVED (P5) |
| SR-005-R2 | PS Integration "5 conditions" | RESOLVED (P8) |
| SM-002-R2 | AGREE-5 ranks 6-12 evidence basis unstated | PERSISTS (not in P1-P10 list; no R3 change detected) |
| SM-003-R2 | Best Case Scenario absent from body | PERSISTS (not addressed in R3) |
| DA-003-R2 | "No source refutes it" hedge phrasing | RESOLVED — DA-001 fix paragraph now more carefully frames null finding |
| DA-004-R2 | AGREE-5 ranks 1-2 scope | RESOLVED (P7) |
| PM-002-R2 | 75/74 reputational risk | RESOLVED (P1) |
| PM-003-R2 | GAP-5 "DO NOT CITE" box placement | PERSISTS — box still follows the claim text rather than preceding it |
| RT-003-R2 | A-31 in "broader academic base" framing | PERSISTS — AGREE-4 still describes A-31 as part of "broader academic base" despite Tier 3 status |
| RT-004-R2 | CONFLICT-2 explanation (4) de-emphasized | PERSISTS — no R3 change to CONFLICT-2 testability ranking |
| CC-002-R2 | THEME-3 causal step lacks cited mechanism | PERSISTS — THEME-3 note mentions synthesis-generated inference but still lacks a cited source |
| CV-002-R2 | Cond-6 traces to synthesis-generated THEME-1 | RESOLVED (P4) |
| CV-003-R2 | Revision Log RT-004 status unstated | PERSISTS — Revision Log R3 entry does not explicitly note RT-004 deferral |
| IN-002-R2 | Circular optimization not in SE-3 | RESOLVED (P9) |
| FM-013 | Alternative hypothesis anchoring | RESOLVED (P6) |

**Summary:** All 10 P1-P10 Priority fixes are RESOLVED. 5 of 14 I2 Minor findings persist (SM-002-R2, SM-003-R2, PM-003-R2, RT-003-R2, RT-004-R2, CC-002-R2, CV-003-R2 — note: some were correctly in the "minor, deferred" category; 6 minor persist).

---

## Tournament Summary Table

| Order | Strategy | New Findings (C/M/m) | Verdict | Key Issue |
|-------|----------|---------------------|---------|-----------|
| 1 | S-010 Self-Refine | 0 Critical / 1 Major / 3 Minor | Proceed with revisions | PS Integration Entry ID still says "R2" (not R3); Deduplication table missing I-1/C-1/C-2 split decision |
| 2 | S-003 Steelman | 0 Critical / 0 Major / 2 Minor | Pass with minor gaps | AGREE-5 ranks 6-12 evidence basis still unstated; Best Case Scenario absent from body |
| 3 | S-002 Devil's Advocate | 0 Critical / 1 Major / 1 Minor | Pass with conditions | DA-003-R2 null finding phrasing improved but epistemically ambiguous phrase persists in one location |
| 4 | S-004 Pre-Mortem | 0 Critical / 0 Major / 2 Minor | Pass | GAP-5 DO NOT CITE box placement still follows claim not precedes it; no new pre-mortem failures |
| 5 | S-001 Red Team | 0 Critical / 0 Major / 2 Minor | Pass | Minor residual framing issue in A-31 "broader academic base" claim; CONFLICT-2 explanation ranking still de-emphasizes hypothesis-relevant option |
| 6 | S-007 Constitutional AI | 0 Critical / 0 Major / 1 Minor | Pass | Minor P-011 residue in THEME-3 causal step; constitutional compliance substantially satisfied |
| 7 | S-011 Chain-of-Verification | 0 Critical / 0 Major / 2 Minor | Pass | Revision Log entry "R2" not updated in PS Integration Entry ID; C-3 (403 inaccessible) counting decision requires caveat |
| 8 | S-012 FMEA | 0 Critical / 0 Major / 1 Minor | Pass | All high-RPN risks resolved; residual low-RPN: AGREE-5 ranks 6-12 ranking evidence |
| 9 | S-013 Inversion | 0 Critical / 0 Major / 1 Minor | Pass | Inversion tests substantially survive; minor: "prohibition works reliably for experts" inversion still only partially addressed |
| 10 | S-014 LLM-as-Judge | — | See scoring section | Multi-dimension rubric applied; leniency bias actively counteracted |

---

## S-010: Self-Refine Findings

**Strategy:** S-010 Self-Refine
**Finding Prefix:** SR
**Protocol Steps Completed:** 6 of 6
**Objectivity Assessment:** High detachment (R3 is a corrections document; reviewer role clearly distinct). Active leniency bias counteraction applied throughout.

**Prior SR findings resolution:**
- SR-001-R2 (Major): Group C sources — RESOLVED (all 13 named)
- SR-002-R2 (Major): 75 vs. 74 inconsistency — RESOLVED (Tier Analysis now 75; Tier 3 = 14)
- SR-003-R2 (Minor): CONFLICT-4 heading — RESOLVED
- SR-004-R2 (Minor): Cond-6/Cond-7 priority — RESOLVED
- SR-005-R2 (Minor): PS Integration condition count — RESOLVED

### New Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| SR-001-R3 | Major | PS Integration "Entry ID" field still reads "Barrier-1-Synthesis-R2" — it was not updated for R3. This creates a traceability discrepancy: the document header says "Revision 3" but the PS Integration metadata identifies R2. Any downstream agent loading this artifact via PS ID key will receive R2 metadata for an R3 document. | PS Integration |
| SR-002-R3 | Minor | Deduplication decisions table omits the C-2 deduplication decision. The body of the Group C catalog notes "I-1 / C-1 are the same document... C-2 is the Anthropic blog — distinct URL, counted separately." However, the Deduplication Decisions table at the bottom of Source Count Verification lists "I-1 / C-1 / C-2 (Anthropic vendor docs)" as "Counted as 1 entry (I-1)" — which contradicts the body text counting C-2 as a separate entry. This is a residual inconsistency in the deduplication decisions table. | Source Count Verification, Deduplication Decisions |
| SR-003-R3 | Minor | The Revision Log R3 entry does not explicitly address the status of RT-004 (circular citation chain in AGREE-4, identified as Major in I1) — specifically whether it was addressed in R2, addressed in R3, or formally deferred. CV-003-R2 (I2 Minor finding) noted this gap; it persists without resolution in R3's Revision Log. | Revision Log |
| SR-004-R3 | Minor | AGREE-5 effectiveness hierarchy ranks 6-12 present the ranking order as given ("Declarative behavioral negation" at rank 9, "Paired prohibition + positive" at rank 10, etc.) without any stated basis for the specific rank ordering within this sub-group. The body note says "varies by specific technique" but does not explain why rank 9 precedes rank 10. A reader applying AGREE-5 to prompt engineering decisions cannot determine whether the intra-subgroup rank ordering is evidential or arbitrary. | L1: AGREE-5 |

### Detailed Finding: SR-001-R3

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | PS Integration |
| **Strategy Step** | Step 3 (Cross-reference verification) |

**Evidence:** PS Integration section contains: "- **Entry ID:** Barrier-1-Synthesis-R2". The document header states: "> ps-synthesizer | Barrier 1 | PROJ-014 | 2026-02-27 | **Revision 3**". The Revision Log section shows three entries: R1, R2, and R3. The PS Integration entry is from R2 and was not updated when R3 changes were made.

**Analysis:** This is a traceability and metadata integrity issue. Any downstream agent or human consumer retrieving this synthesis by PS ID will find "Barrier-1-Synthesis-R2" as the identifier, inconsistent with the document being Revision 3. The constitutional compliance footer also still reads "Self-review (S-010) applied" without specifying which revision this applies to, but more critically the PS Entry ID mismatch could cause routing or citation errors in the orchestration chain.

**Recommendation:** Update PS Integration Entry ID to "Barrier-1-Synthesis-R3" and update the artifact description line to note "Revision 3 (R3)."

---

### Detailed Finding: SR-002-R3

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | Source Count Verification, Deduplication Decisions |
| **Strategy Step** | Step 2 (Internal consistency check) |

**Evidence:** Group C catalog entry for C-2 states: "Distinct URL and publication from C-1/I-1 (platform.claude.com). Same vendor family, different document." Count Status: "COUNTED — distinct URL from I-1/C-1." The Deduplication Decisions note separately states: "I-1 / C-1 are the same document (Anthropic platform docs). Counted ONCE as I-1. C-2 is the Anthropic blog — distinct URL, counted separately." However, the Deduplication Decisions table row reads: "I-1 / C-1 / C-2 (Anthropic vendor docs) | Same vendor documentation family | Counted as 1 entry (I-1)." This table row incorrectly groups C-2 with the deduplicated I-1/C-1 pair.

**Analysis:** The table row is a copy-paste artifact from the prior version that grouped all three together. The narrative text (both in the Group C catalog and the prose deduplication note) correctly treats C-2 as distinct. The table row is the inconsistency. This is Minor because the correct logic appears in both the catalog and the prose; only the summary table is wrong.

**Recommendation:** Correct the Deduplication Decisions table row to separate "I-1 / C-1 (Anthropic platform docs) | Identical source | Counted as 1 entry (I-1)" from a separate row "C-2 (Anthropic Prompt Engineering Blog) | Distinct URL, different document | Counted separately."

---

### Scoring Impact (S-010)

| Dimension | Weight | Impact | Rationale |
|-----------|--------|--------|-----------|
| Completeness | 0.20 | Positive | All major I2 completeness gaps addressed |
| Internal Consistency | 0.20 | Positive | 75/74 inconsistency resolved; one new minor inconsistency (deduplication table C-2) introduced |
| Methodological Rigor | 0.20 | Positive | SE-5 publication bias added |
| Evidence Quality | 0.15 | Positive | No new evidence quality concerns |
| Actionability | 0.15 | Positive | Cond-6/Cond-7 priority signals added; PS Integration complete |
| Traceability | 0.10 | Slightly Negative | PS Entry ID R2 vs. R3 is a traceability artifact; deduplication table C-2 minor gap |

**Decision:** Proceed to S-003. One new Major finding (SR-001-R3 PS Entry ID) and three Minor findings. Net improvement from R2. Major finding is an administrative metadata artifact, not a substantive error.

---

## S-003: Steelman Findings

**Strategy:** S-003 Steelman Technique
**Finding Prefix:** SM
**Protocol Steps Completed:** 6 of 6
**H-16 Verification:** Executing before S-002. SATISFIED.
**Core Thesis (R3):** "Across 75 unique sources (verified), the PROJ-014 working hypothesis is a null finding (untested, not refuted); blunt prohibition is unreliable; 9 agreements identified; Phase 2 7-condition design with explicit priority ordering specified; all major I2 findings addressed."

**Prior SM findings addressed:**
- SM-001-R2 (Major): Cond-6/Cond-7 priority — RESOLVED
- SM-002-R2 (Minor): AGREE-5 ranks 6-12 evidence basis — PERSISTS (not addressed in R3)
- SM-003-R2 (Minor): Best Case Scenario absent — PERSISTS (not addressed in R3)

### New Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| SM-001-R3 | Minor | AGREE-5 ranks 6-12 (the prompt-engineering-accessible range) still lack any stated evidence basis for the intra-subgroup ordering. The synthesis's strongest actionable output is this hierarchy, yet a practitioner cannot determine whether "Declarative behavioral negation" (rank 9) should be prioritized over "Paired prohibition + positive" (rank 10) based on any documented evidence. The hierarchy within ranks 5-12 is the primary decision-relevant comparison for PROJ-014. | L1: AGREE-5 effectiveness hierarchy |
| SM-002-R3 | Minor | The "Best Case Scenario" — an explicit articulation of the conditions under which this synthesis is most compelling and reliable — was recommended by S-003 in I1 (SM-005) and I2 (SM-003-R2) but remains absent from the synthesis body. Given that R3 is the third revision targeting C4 quality, the absence of a steelman best-case statement in the document itself (not just in the adversary report) is a persistent gap in the synthesis's own advocacy for its conclusions. | General / L0 |

### Steelman Assessment (R3)

**Strongest form of the R3 synthesis:**
1. **Source coverage:** 75 verified unique sources across three independent surveys — the most comprehensive public evidence base on negative prompting compiled to date.
2. **Methodological transparency:** Known Scope Exclusions now documents 5 exclusion domains (SE-1 through SE-5) — this is more systematic than most practitioner-facing syntheses. The synthesis models ideal epistemic humility about what it cannot know.
3. **Null finding precision:** The distinction between "hypothesis untested" and "hypothesis refuted" is now explicit and prominent — this is methodologically correct and prevents the most common misinterpretation.
4. **Actionable design:** The 7-condition Phase 2 design with explicit Recommended-A/Recommended-B prioritization is directly usable by a Phase 2 analyst without additional judgment about what to test.
5. **Scope clarity:** The AGREE-5 scope note now prevents misleading comparisons between prompt-accessible and infrastructure-required techniques.

**Decision:** Proceed to S-002. No new Major findings from steelman review. R3 has substantially strengthened the synthesis's defensibility. Two residual minor gaps (intra-AGREE-5 ranking basis, best-case statement) are genuine but not disqualifying.

---

## S-002: Devil's Advocate Findings

**Strategy:** S-002 Devil's Advocate
**Finding Prefix:** DA
**Protocol Steps Completed:** 5 of 5
**H-16 Verification:** S-003 executed prior. SATISFIED.

**Prior DA findings addressed:**
- DA-001-R2 (Major): Vendor bias caveat in AGREE-3 — RESOLVED
- DA-002-R2 (Major): Alternative hypothesis placement — RESOLVED
- DA-003-R2 (Minor): "No source refutes it" hedge — PARTIALLY RESOLVED (see below)
- DA-004-R2 (Minor): AGREE-5 scope — RESOLVED

### New Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| DA-001-R3 | Major | The epistemic distinction paragraph in L0 (DA-001/RT-001 fix) contains the sentence: "No source confirms the claim; no source has refuted it with controlled data either." The second clause "no source has refuted it with controlled data" is technically accurate but structurally parallel to the first clause ("no source confirms it") in a way that implies symmetric evidentiary status. This is not epistemically symmetric: there are many sources showing that standalone prohibition instructions have failure modes (AGREE-4, 5 Strong agreements, multiple Tier 1 papers), while there are zero sources showing 60% hallucination reduction. Presenting the two clauses as parallel creates a false balance in L0 that is accessible to misreading as "equal evidence on both sides." | L0: Executive Summary, epistemic distinction paragraph |
| DA-002-R3 | Minor | The AGREE-4 "Note on circular citation risk (RT-004)" states: "the academic base for this agreement is broader than the industry citation network implies, resting on multiple independent academic sources (A-20, A-19, A-31)." A-31 (Bsharat et al., Tier 3 arXiv preprint) is included as an independent source, but an arXiv preprint that has not been peer-reviewed cannot be treated as independently validating the finding in the same way as A-20 (Tier 1, AAAI 2026) or A-19 (Tier 3 but large-scale, 13 models). The claim of independence from the practitioner network is asserted but not demonstrated. | L1: AGREE-4 |

### Detailed Finding: DA-001-R3

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L0: Executive Summary, epistemic distinction paragraph |
| **Strategy Step** | Step 2 (Assumption identification) |

**Evidence:** The L0 epistemic distinction paragraph reads: "The absence of supporting evidence is a null finding — it means the hypothesis has not been tested in controlled conditions, not that it has been refuted. No source confirms the claim; no source has refuted it with controlled data either."

AGREE-4 (Strong, all 3 surveys) documents that prohibition-style negative instructions are unreliable as standalone mechanisms — supported by A-20 (Tier 1, AAAI 2026), A-19 (Tier 3, 13 models), A-31 (Tier 3), and industry/context7 corroboration. This is not "no evidence": this is a convergent finding across 5 Strong agreements and 4 Moderate agreements in the synthesis's own body. The claim "no source has refuted it" applies specifically to the 60% hallucination-reduction hypothesis, but the parallel construction with "no source confirms the claim" creates ambiguity about whether the synthesis is asserting that there is no evidence bearing on the question at all — which overstates the evidential vacuum.

**Analysis:** The synthesis correctly aims to distinguish "null finding on the specific 60% claim" from "refutation of all negative prompting." But the sentence structure compresses two distinct claims: (1) the 60% hypothesis has not been tested, and (2) blunt prohibition-style instructions show consistent failure patterns in the literature. Presenting (1) and (2) as parallel ("no source confirms / no source refutes") obscures that (2) is actually well-supported by the synthesis's own AGREE-4. A careful reader can disentangle this; a casual reader may not.

**Recommendation:** Revise the L0 epistemic distinction paragraph to read: "The absence of evidence for the specific 60% hallucination-reduction claim is a null finding — this precise claim has not been tested in controlled conditions. Separately, there is convergent multi-survey evidence (AGREE-4, AGREE-5) that standalone prohibition-style instructions are unreliable as behavioral constraints; these are distinct findings bearing on different aspects of negative prompting. The synthesis's primary result is that the 60% claim specifically lacks any supporting or refuting controlled evidence."

---

### Scoring Impact (S-002)

| Dimension | Impact |
|-----------|--------|
| Completeness | Neutral (one new Major, minor text clarification needed) |
| Internal Consistency | Slightly negative (DA-001-R3 creates minor logical tension in L0) |
| Methodological Rigor | Neutral |
| Evidence Quality | Neutral |

**Decision:** Proceed to S-004. One new Major finding (DA-001-R3) is real but addressable with a sentence-level revision. No new Critical findings.

---

## S-004: Pre-Mortem Findings

**Strategy:** S-004 Pre-Mortem Analysis
**Finding Prefix:** PM
**Protocol Steps Completed:** 5 of 5

**Prior PM findings addressed:**
- PM-001-R2 (Major): Cond-7 label — RESOLVED
- PM-002-R2 (Minor): 75/74 reputational risk — RESOLVED
- PM-003-R2 (Minor): GAP-5 "DO NOT CITE" placement — PERSISTS (no R3 change)

### Pre-Mortem Scenarios (R3)

**Scenario 1: "The Phase 2 analyst misimplements the experimental design."**
- R3 mitigation: 7 conditions with Required/Recommended-A/Recommended-B priority labels. Derivation traces. Mandatory measurement dimensions. Design constraints. *Survivability: SUBSTANTIALLY IMPROVED.*

**Scenario 2: "A reviewer challenges the source count."**
- R3 mitigation: All 13 Group C sources named. Explicit arithmetic trace with full table. Deduplication decisions documented. Tier Analysis totals match L0. *Survivability: SUBSTANTIALLY IMPROVED.* Residual minor: deduplication table C-2 row (SR-002-R3).

**Scenario 3: "A secondary researcher cites the synthesis incorrectly as refuting negative prompting."**
- R3 mitigation: Epistemic distinction note present and prominent. Known Scope Exclusions SE-5 added. *Survivability: IMPROVED.* Residual: DA-001-R3 parallel construction may still enable misreading.

**Scenario 4: "The PS routing system retrieves R2 instead of R3."**
- R3 failure: PS Entry ID still says "R2" (SR-001-R3). *Survivability: FAILS.*

**Scenario 5: "A Phase 2 analyst includes Cond-6 without understanding its exploratory status."**
- R3 mitigation: Cond-6 prominently labeled as synthesis-generated hypothesis. Negative results caveat explicit. *Survivability: SUBSTANTIALLY IMPROVED.*

### New Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| PM-001-R3 | Minor | GAP-5 "DO NOT CITE WITHOUT VERIFICATION" box still appears after the specific figures (95%→20-60% decay rates) rather than before them. A reader who stops reading mid-GAP-5 will have absorbed the unverified figures without seeing the caveat. The caveat should precede or be co-located with the claim. This is a persistent Minor from I2 (PM-003-R2). | L1: Gaps, GAP-5 |
| PM-002-R3 | Minor | The failure mode "PS routing system retrieves R2 metadata for R3 document" (SR-001-R3 mapped to pre-mortem) is not a hypothetical — it is a current state in the synthesis. The PS Entry ID reads "R2." Any orchestration pipeline using this Entry ID as a key will not distinguish R2 from R3. This creates a concrete version management risk. | PS Integration |

---

## S-001: Red Team Findings

**Strategy:** S-001 Red Team Analysis
**Finding Prefix:** RT
**Protocol Steps Completed:** 5 of 5

**Prior RT findings addressed:**
- RT-001-R2 (Major): SE-5 publication bias — RESOLVED
- RT-002-R2 (Major): AGREE-5 scope delineation — RESOLVED
- RT-003-R2 (Minor): A-31 "academic base breadth" framing — PERSISTS (no R3 change to AGREE-4 circular citation note)
- RT-004-R2 (Minor): CONFLICT-2 explanation (4) de-emphasized — PERSISTS (no R3 change to CONFLICT-2)

### New Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| RT-001-R3 | Minor | AGREE-4 note on circular citation risk states: "the academic base for this agreement is broader than the industry citation network implies, resting on multiple independent academic sources (A-20, A-19, A-31)." A-31 (Bsharat et al., arXiv, Tier 3, unreviewed) is included in this list as if it provides comparable independence validation to A-20 (Tier 1, AAAI 2026) and A-19 (large-scale, 13 models). An adversarial reader could argue that including an unreviewed preprint as evidence of "broader academic base" is itself a form of citation inflation. The note should distinguish tier levels within the list. | L1: AGREE-4 |
| RT-002-R3 | Minor | CONFLICT-2 explanation (4) — "pragmatic recognition that some constraints are most clearly expressed as prohibitions" — is ranked "least testable" despite being the explanation most directly relevant to PROJ-014's working hypothesis. Ranking the most hypothesis-relevant alternative as "least testable" systematically de-emphasizes it. A Phase 2 analyst reading CONFLICT-2 will see explanation (1) (intention-dependent) as most testable and spend experimental design resources there, potentially under-testing the most practically important alternative. | L1: CONFLICT-2 |

### Adversarial Attack Surface Assessment (R3)

**Attack 1: "The synthesis's null finding is artifactual — it reflects the surveys' publication bias."**
- R3 defense: SE-5 explicitly acknowledges publication bias. *Defense: STRONG.*

**Attack 2: "AGREE-4 rests on a rejected paper (A-16) and circular Tier 3 citations."**
- R3 defense: A-16 demoted to "corroborating caveat"; AGREE-4 now leads with A-20 (Tier 1) and A-19. Circular citation note present. *Defense: SUBSTANTIALLY IMPROVED.*

**Attack 3: "The 60% claim is untested — you can't conclude it's wrong."**
- R3 defense: Epistemic distinction note explicit; "null finding, not refutation" language present. *Defense: STRONG.*

**Attack 4: "The Phase 2 design is contaminated by synthesis assumptions (Cond-6)."**
- R3 defense: Cond-6 explicitly labeled as synthesis-generated hypothesis with exploratory note. *Defense: SUBSTANTIALLY IMPROVED.*

**Attack 5: "Vendor recommendations may just reflect their own training optimization."**
- R3 defense: DA-001-R2 fix now in AGREE-3 with explicit vendor neutrality caveat. *Defense: STRONG.*

---

## S-007: Constitutional AI Findings

**Strategy:** S-007 Constitutional AI Critique
**Finding Prefix:** CC
**Protocol Steps Completed:** 4 of 4

**Prior CC findings addressed:**
- CC-001-R2 (Major): P-022 issue (75 vs. 74) — RESOLVED
- CC-002-R2 (Minor): THEME-3 causal step — PERSISTS (no R3 change)

### Constitutional Compliance Review (R3)

| Principle | Assessment | Finding |
|-----------|------------|---------|
| P-001 (Truth/Accuracy) | PASS | Null finding language correct; Tier 3 evidence properly qualified throughout; vendor bias caveat added |
| P-003 (No Recursion) | PASS | Standalone synthesis document; no subagent delegation |
| P-004 (Provenance) | PASS | All 13 Group C sources now named; arithmetic trace complete; all major claims retain source attribution |
| P-011 (Evidence-Based) | PARTIAL | THEME-3 causal inference about GPT-5.2 behavior still lacks cited source for the mechanism; minor residue |
| P-020 (User Authority) | PASS | Research recommendations are suggestions; Phase 2 decisions correctly deferred to researchers |
| P-022 (No Deception) | PARTIAL | PS Entry ID "R2" vs. document "R3" is a minor factual discrepancy; DA-001-R3 parallel construction in L0 creates mild framing ambiguity |

### New Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| CC-001-R3 | Minor | P-022 minor residue: PS Integration Entry ID reads "Barrier-1-Synthesis-R2" while the document is Revision 3. This is a factual statement in the document that is incorrect, creating a minor P-022 issue. It is administrative but detectable and should be corrected. (Same as SR-001-R3 from a constitutional compliance perspective.) | PS Integration |

### Constitutional Compliance Summary (R3)

R3 has substantially resolved the major constitutional compliance issues from I1 and I2. P-001 and P-022 compliance are now strong except for the minor PS Entry ID artifact. P-011 has one residual minor concern (THEME-3 mechanism claim). Overall constitutional compliance is HIGH.

---

## S-011: Chain-of-Verification Findings

**Strategy:** S-011 Chain-of-Verification
**Finding Prefix:** CV
**Protocol Steps Completed:** 5 of 5

**Prior CV findings addressed:**
- CV-001-R2 (Major): Group C sources — RESOLVED
- CV-002-R2 (Minor): Cond-6 traces to THEME-1 — RESOLVED
- CV-003-R2 (Minor): Revision Log RT-004 status — PERSISTS (R3 Revision Log does not address RT-004 deferral)

### Verification Questions (R3)

| Claim | Verification Question | Source | Verified? | Finding |
|-------|----------------------|--------|-----------|---------|
| "75 unique sources" | Does 31 + 31 + 13 = 75? | Source Count Verification, arithmetic trace | VERIFIED | Arithmetic correct; Tier Analysis updated to 75 |
| "Group C = 13 sources" | Are all 13 explicitly named? | Source Count Verification | VERIFIED | C-2, C-3, C-6, C-7, C-8, C-9, C-10, C-11, C-12, C-13, C-14, C-19, C-20 — all 13 enumerated |
| "Tier 3 = 14 sources" | Are all 14 Tier 3 sources listed? | Evidence Tier Analysis | VERIFIED | 15 listed in the Tier 3 count note: A-2, A-5, A-6, A-10, A-11, A-14, A-16, A-17, A-18, A-19, A-21, A-29, A-31, C-13, C-19 — that is 15, but count says 14 |
| "5 Strong agreements" | Are AGREE-1 through AGREE-5 all present? | L1: Agreements | VERIFIED | All 5 Strong agreements present |
| "4 Moderate agreements" | Are AGREE-6 through AGREE-9 all present? | L1: Agreements | VERIFIED | All 4 Moderate agreements present |
| "SE-5 publication bias added" | Is SE-5 present in Known Scope Exclusions? | Known Scope Exclusions | VERIFIED | SE-5 present and correctly described |
| "Cond-7 = Recommended-A, Cond-6 = Recommended-B" | Do Phase 2 conditions table labels match PS Integration? | Phase 2 Design / PS Integration | VERIFIED | Consistent across both sections |
| "AGREE-3 vendor neutrality caveat added" | Is the circular optimization caveat present? | L1: AGREE-3 | VERIFIED | Caveat present, appropriately phrased |
| "C-3 (403 inaccessible) counted as unique source" | Should a source that returned 403 and was never successfully fetched be counted? | Group C catalog / Source Count Verification | PARTIAL — see CV-001-R3 below |
| "Deduplication decision for C-2 correct" | Does the deduplication table match the catalog entry? | Source Count Verification | PARTIAL — SR-002-R3 conflict |

### New Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| CV-001-R3 | Minor | The Tier 3 count note in Evidence Tier Analysis lists 15 sources: A-2, A-5, A-6, A-10, A-11, A-14, A-16, A-17, A-18, A-19, A-21, A-29, A-31, C-13, C-19 = 15 distinct source IDs. However, the total states "14 sources" for Tier 3. The arithmetic 13 + 5 + 14 + 43 = 75 requires Tier 3 to be exactly 14. If there are genuinely 15 Tier 3 sources, either the total would be 76 or one of the other tiers needs a corresponding reduction. This is a count-in-note vs. count-in-header discrepancy introduced by R3's tier count correction. | L1: Evidence Tier Analysis, Tier 3 count note |
| CV-002-R3 | Minor | C-3 (OpenAI Prompt Engineering Guide, platform.openai.com) was inaccessible at 403 during the context7 survey but is counted as one of the 13 Group C unique sources. Counting an inaccessible source raises a methodological question: if the content was never retrieved, the "key finding" attributed to C-3 ("Primary OpenAI platform docs; 'say what to do instead of what not to do'") is inferred from the URL and prior knowledge, not from direct content retrieval. The catalog entry appropriately notes "Inaccessible at 403 but referenced in context7 survey" — but the implication for the synthesis's evidence chain (can we cite a document we could not access?) is not explicitly addressed. | Group C catalog, C-3 entry |

### Detailed Finding: CV-001-R3

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | L1: Evidence Tier Analysis |
| **Strategy Step** | Step 3 (Source traceability) |

**Evidence:** The Tier 3 count note reads: "The Tier 3 category counts 14 sources: A-2, A-5, A-6, A-10, A-11, A-14, A-16, A-17, A-18, A-19, A-21, A-29, A-31, C-13, C-19." Counting the listed sources: A-2 (1), A-5 (2), A-6 (3), A-10 (4), A-11 (5), A-14 (6), A-16 (7), A-17 (8), A-18 (9), A-19 (10), A-21 (11), A-29 (12), A-31 (13), C-13 (14), C-19 (15) = 15 items. The header says "14 sources." One item is over-counted relative to the stated total of 14. The arithmetic 13 + 5 + 14 + 43 = 75 is internally consistent only if exactly 14 Tier 3 sources. If there are actually 15 Tier 3, either the total should be 76 or one source is miscounted in another tier.

**Analysis:** A likely explanation: the original Tier 3 list (before R3) counted 13 sources (without A-31). R3 added A-31, making it 14. But the corrected note listed all 15 including C-19 (which was already in the prior count). Counting suggests C-19 was already counted in the 13 before R3's A-31 addition. If so, the list should have 14 items (the prior 13 + A-31) not 15, suggesting one source is duplicated or miscounted in the enumerated list.

**Recommendation:** Recount the Tier 3 list. If the pre-R3 list had 13 Tier 3 sources that included C-19, then adding A-31 yields 14 — and the note should list only 14 sources, removing one duplicate from the enumerated list (most likely C-19 was already in the pre-R3 13 and should be verified as not double-listed).

---

## S-012: FMEA Findings

**Strategy:** S-012 FMEA
**Finding Prefix:** FM
**Protocol Steps Completed:** 5 of 5

**Prior FM high-RPN findings addressed:**
- FM-010 (Major, RPN 216): Source count inconsistency — RESOLVED
- FM-011 (Major, RPN 200): Group C unidentified sources — RESOLVED
- FM-012 (Major, RPN 210): Cond-7 label — RESOLVED
- FM-013 (Medium, RPN 144): Alternative hypothesis anchoring — RESOLVED

### Updated FMEA Risk Table (R3)

RPN = Severity (1-10) × Occurrence (1-10) × Detectability (1-10)

| ID | Failure Mode | Component | Sev | Occ | Det | RPN | Status |
|----|-------------|-----------|-----|-----|-----|-----|--------|
| FM-001 | Agreement count error propagates | L0 Key Numbers | 8 | 1 | 3 | 24 | RESOLVED — substantially reduced |
| FM-002 | Null finding misread as directional | L0 Executive Summary | 7 | 3 | 4 | 84 | SUBSTANTIALLY REDUCED — epistemic note + SE-5; DA-001-R3 parallel construction residue |
| FM-003 | Unverified Tier 4 figures cited as fact | L1: Gaps | 7 | 3 | 4 | 84 | PARTIALLY REDUCED — DO NOT CITE boxes present; GAP-5 placement still sub-optimal |
| FM-010 | Source count inconsistency | L0/Tier Analysis | 6 | 1 | 2 | 12 | RESOLVED from RPN 216 |
| FM-011 | Group C sources unverifiable | Source Count | 5 | 1 | 2 | 10 | RESOLVED from RPN 200 |
| FM-012 | Cond-7 omitted despite Tier 1 evidence | Phase 2 Design | 7 | 2 | 3 | 42 | RESOLVED from RPN 210 |
| FM-014 | PS Entry ID R2/R3 mismatch causes routing error | PS Integration | 5 | 5 | 6 | 150 | NEW — medium-high RPN |
| FM-015 | Tier 3 count note lists 15 sources, header says 14 | Evidence Tier Analysis | 4 | 4 | 5 | 80 | NEW (CV-001-R3) |
| FM-016 | DA-001-R3 parallel construction ambiguity misread as false balance | L0 Epistemic Distinction | 6 | 4 | 5 | 120 | NEW — medium RPN |
| FM-006 | Deduplication verification fails (C-2 table row) | Source Count | 3 | 3 | 4 | 36 | REDUCED from prior; minor residue |

### New FMEA Finding: FM-014

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | PS Integration |
| **RPN** | 150 |

**Evidence:** FM-014 is the FMEA representation of SR-001-R3. The PS Integration Entry ID "Barrier-1-Synthesis-R2" for an R3 document creates a version mismatch with Occurrence=5 (this will be encountered by every downstream agent loading the synthesis) and Detectability=6 (a downstream agent would need to cross-reference the document header with the Entry ID to detect the mismatch, which is not automatic).

**Recommendation:** Update Entry ID to "Barrier-1-Synthesis-R3" before handoff to ps-analyst.

---

### New FMEA Finding: FM-016

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | L0: Executive Summary, epistemic distinction paragraph |
| **RPN** | 120 |

**Evidence:** FM-016 is the FMEA representation of DA-001-R3. The L0 epistemic distinction paragraph's parallel construction ("no source confirms / no source refutes") has Severity=6 (false balance in a research synthesis is a meaningful misrepresentation risk), Occurrence=4 (a reader who reads L0 closely but not the body will encounter this), Detectability=5 (the rest of L0 provides context but the sentence itself is self-contained and could be extracted).

---

## S-013: Inversion Findings

**Strategy:** S-013 Inversion Technique
**Finding Prefix:** IN
**Protocol Steps Completed:** 5 of 5

**Prior IN findings addressed:**
- IN-001-R2 (Major): Cond-6 amplifying synthesis hypothesis — RESOLVED
- IN-002-R2 (Minor): Circular optimization in SE-3 — RESOLVED (DA-001-R2 fix now in AGREE-3)

### Inversion Test (R3)

| Major Finding | Inverted Assumption | Survivability |
|---------------|---------------------|---------------|
| "No evidence supports 60% claim" | What if 60% IS well-supported in production contexts? | SURVIVES — SE-1 through SE-5 explicitly bound the null finding to public evidence domains |
| "Prohibition-style instructions are unreliable" | What if prohibition works reliably for expert prompt engineers using domain-specific precision? | PARTIALLY FAILS — AGREE-4 documents aggregate failure across large studies; expert user exception still not explicitly controlled for |
| "Structured alternatives outperform blunt prohibition" | What if structured alternatives work for different mechanistic reasons, making framing comparison irrelevant? | SURVIVES — THEME-5 explicit caveat: "These are separate claims" |
| "Phase 2 design tests the right 7 conditions" | What if the conditions are incomplete or the wrong ones? | SUBSTANTIALLY IMPROVED — Cond-6 now labeled exploratory; Cond-7 prioritized over Cond-6 by evidence tier |
| "Vendor consensus means positive framing is generally better" | What if vendor recommendations are circular optimizations for vendor-trained models only? | SURVIVES — DA-001-R2 fix in AGREE-3 explicitly acknowledges this concern |
| "75 sources is a robust evidence base" | What if the source count is the most comprehensive but still fundamentally incomplete for causal claims? | SURVIVES — SE-1 through SE-5 scope limitations explicitly bound all conclusions to public evidence |

### New Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| IN-001-R3 | Minor | The inversion "What if prohibition-style instructions work reliably for expert prompt engineers who understand model-specific nuances?" is tested in AGREE-4 but the synthesis only documents aggregate failure rates. The synthesis implicitly assumes that user expertise is not a significant moderating variable. No AGREE section, GAP entry, or CONFLICT resolution addresses user expertise as an independent variable. This gap was identified in I1 (IN-004) and I2 (AGREE-4 note at "PARTIALLY FAILS") and persists in R3 without explicit acknowledgment. | L1: AGREE-4 |

---

## S-014: LLM-as-Judge Scoring

**Strategy:** S-014 LLM-as-Judge
**Finding Prefix:** LJ
**Protocol Steps Completed:** 7 of 7

**Anti-leniency controls applied:**
- All uncertain scores resolved downward
- C4 threshold is 0.95 — actively applied
- Score trajectory (0.83 → 0.90 → ?) used to calibrate expectation; improvement should be proportional to identified fixes
- Each dimension scored independently before compositing
- Evidence cited for every score in both directions (for and against)

---

### Dimension 1: Completeness (weight: 0.20)

**Score: 0.94**

**Evidence FOR higher score:**
- All 3 I1 Critical findings resolved — STRONG (DA-001, DA-002/CC-002, IN-001)
- All P1-P10 I2 priority fixes resolved — STRONG
- SE-5 (publication bias) added — meaningful methodological completeness gain
- All 13 Group C sources explicitly enumerated — completeness verified
- 7-condition Phase 2 design with Recommended-A/B priority — complete
- Vendor neutrality caveat in AGREE-3 — completeness gain
- Alternative hypothesis correctly positioned — structural completeness gain
- PS Integration updated to 7 conditions — consistent

**Evidence AGAINST higher score:**
- SM-002-R3 (Best Case Scenario absent): The synthesis lacks an explicit articulation of its own strongest case — a minor but genuine completeness gap, especially for a C4 deliverable
- IN-001-R3 (expert user variable): User expertise as a moderating variable for AGREE-4 is never addressed; a methodologically complete synthesis of instructional effectiveness research should note this
- PS Entry ID R2/R3 mismatch: Minor administrative incompleteness

**Justification for 0.94:** Major improvement from I2's 0.91. All structural completeness requirements are met. The residual gaps (best case statement, expert user variable) are genuine but minor relative to the substantial gains. The 0.94 reflects "near-comprehensive with two specific minor omissions." Would need Best Case Scenario and IN-001-R3 acknowledgment to reach 0.96.

---

### Dimension 2: Internal Consistency (weight: 0.20)

**Score: 0.92**

**Evidence FOR higher score:**
- 75 vs. 74 inconsistency fully resolved — STRONG (primary I2 Internal Consistency issue)
- Agreement count verified: 5 Strong + 4 Moderate = 9 total, consistent throughout — STRONG
- CONFLICT-4 heading now qualified — resolved
- PS Integration condition count now matches Phase 2 Design section — resolved
- L0 alternative hypothesis position consistent with Phase 2 mandate framing — resolved
- "A-31 replaces I-13" language removed — resolved

**Evidence AGAINST higher score:**
- CV-001-R3: Tier 3 count note lists 15 sources while header says 14 — new minor inconsistency introduced by R3
- SR-002-R3: Deduplication decisions table shows C-2 grouped with I-1/C-1 while catalog correctly shows C-2 as distinct — minor inconsistency
- DA-001-R3: L0 epistemic distinction paragraph's parallel construction creates mild logical tension between "no source confirms" and "no source refutes" — these are not equivalent evidential claims given AGREE-4's strength
- PS Entry ID: R2 in a R3 document — minor administrative inconsistency

**Justification for 0.92:** Strong improvement from I2's 0.88. The primary consistency issue (75/74) is definitively resolved. The residual issues are genuinely minor — a Tier 3 count enumeration mismatch (15 listed vs. 14 stated), a deduplication table row artifact, and a sentence-level framing tension. These prevent reaching 0.95+ but 0.92 accurately reflects "substantially consistent with small residual issues." Score of 0.92 is at the H-13 general threshold but still below C4's 0.95 requirement.

---

### Dimension 3: Methodological Rigor (weight: 0.20)

**Score: 0.93**

**Evidence FOR higher score:**
- SE-5 publication bias now explicitly acknowledged — addresses a standard systematic review standard gap
- Braun & Clarke (2006) methodology consistently applied throughout — STRONG
- Known Scope Exclusions now 5 domains (SE-1 through SE-5) — comprehensive
- Cond-6 labeled as exploratory synthesis hypothesis — methodological integrity preserved
- AGREE-5 scope delineation prevents cross-level comparison errors — methodological precision gain
- AGREE-4 restructured to lead with Tier 1 evidence — hierarchy respect
- Evidence tier assignments reviewed and accurate throughout
- Per-agreement confidence qualifiers maintained from R2

**Evidence AGAINST higher score:**
- CC-002-R2 (THEME-3 mechanism): The inference that GPT-5.2 following flawed instructions "too literally" produces "confidently wrong output" still lacks a cited mechanism — it remains a synthesis-generated speculation without source support, despite the caveat label
- IN-001-R3 (expert user variable): Absence of any discussion of user expertise as a moderating variable is a methodological gap for a synthesis claiming to characterize instructional effectiveness generally
- SM-001-R3 (AGREE-5 intra-subgroup ranking): The specific rank ordering of techniques within ranks 6-12 lacks any stated basis — methodologically, presenting an ordering without basis implies false precision

**Justification for 0.93:** Strong improvement from I2's 0.90. Publication bias acknowledgment was the primary methodological gap and is now addressed. The residual issues are minor: one speculative causal step in THEME-3, one absent user-expertise variable note, one unstated ranking basis within a sub-group. Score of 0.93 reflects "rigorous methodology with three specific but minor gaps." Slightly below C4's 0.95 but well above H-13's 0.92.

---

### Dimension 4: Evidence Quality (weight: 0.15)

**Score: 0.92**

**Evidence FOR higher score:**
- All I1 and I2 evidence quality issues resolved — STRONG
- Tier 3 count note now correctly distinguishes A-31 as net-new (not replacing I-13) — STRONG
- Vendor neutrality caveat in AGREE-3 addresses circular optimization concern — quality gain
- AGREE-5 scope note prevents misleading tier comparisons — quality gain
- All Tier 4 sources in Gaps section have appropriate DO NOT CITE caveats or uncertainty language
- A-16 (rejected paper) consistently demoted throughout document
- C-13 (DSPy preprint) correctly marked Tier 3 throughout

**Evidence AGAINST higher score:**
- CV-001-R3: Tier 3 count note lists 15 sources but states 14 — minor arithmetic artifact affecting tier analysis credibility
- RT-001-R3 (AGREE-4): A-31 presented as independently validating "broader academic base" despite being Tier 3 unreviewed — minor but residual
- CV-002-R3 (C-3 at 403): A source that could not be retrieved is counted in the catalog; the key finding attributed to C-3 is inferred from URL and prior knowledge, not direct content retrieval

**Justification for 0.92:** Strong improvement from I2's 0.90. Major evidence quality issues from I1 and I2 are all resolved. The residual issues are minor: one count arithmetic artifact, one mild tier-independence inflation, one inaccessible-source inclusion without explicit epistemological caveat. Score of 0.92 reflects "high evidence quality with minor technical gaps."

---

### Dimension 5: Actionability (weight: 0.15)

**Score: 0.95**

**Evidence FOR higher score:**
- 7-condition Phase 2 design with Required/Recommended-A/Recommended-B labels — STRONGLY actionable
- Derivation traces from source to finding to condition — complete
- Mandatory measurement dimensions specified — complete
- Design constraints explicit ("post-2024 models only"; "document model version") — complete
- Access-level annotations in AGREE-5 distinguish prompt-only from infra-required — complete
- PS Integration updated to reference all 7 conditions with priority labels — navigable handoff
- Alternative hypothesis repositioned to prevent Phase 2 anchoring — actionability protection
- Warning-based meta-prompt (A-23, Tier 1) identified as most actionable Tier 1 finding — clear priority signal

**Evidence AGAINST higher score:**
- SM-001-R3 (AGREE-5 intra-subgroup ranks 6-12): The ranking within the prompt-accessible sub-group lacks evidential basis — a practitioner trying to choose between ranks 9 and 10 receives no guidance
- IN-001-R3 (expert user variable): Phase 2 experimental design does not control for user expertise; a resource-constrained Phase 2 design may produce results confounded by experimenter skill levels

**Justification for 0.95:** This is the synthesis's strongest dimension in R3. The Phase 2 design section is comprehensive, prioritized, and traceable. The actionability gains from R2 and R3 are substantial. The residual gaps are minor and do not materially impede the primary use case of the synthesis (informing Phase 2 design). Score of 0.95 is the highest in this dimension and is evidence-justified.

---

### Dimension 6: Traceability (weight: 0.10)

**Score: 0.93**

**Evidence FOR higher score:**
- All 75 source IDs now traceable to catalog entries — STRONG
- All 13 Group C sources explicitly named with context7 reference numbers — STRONG
- Source Count Verification arithmetic trace complete and independently verifiable — STRONG
- All Phase 2 conditions have explicit derivation traces — STRONG
- Deduplication decisions documented in narrative and table — STRONG
- AGREE entries cite specific survey sections and direct quotes — STRONG (unchanged)
- Revision Log documents all R3 changes with finding IDs addressed — STRONG

**Evidence AGAINST higher score:**
- SR-001-R3 (PS Entry ID R2): Traceability discrepancy in the PS Integration metadata
- CV-001-R3 (Tier 3 list discrepancy): Count note lists 15 sources but states 14 — audit readers will encounter a one-item discrepancy
- SR-002-R3 (deduplication table C-2): Minor traceability inconsistency in the table vs. narrative
- CV-003-R2 (persisting): Revision Log R3 entry does not address RT-004 (circular citation chain) status — the finding from I1 is neither resolved nor explicitly deferred in the log

**Justification for 0.93:** Strong improvement from I2's 0.90. The primary traceability advance in R3 is the complete enumeration of all 13 Group C sources. The residual gaps are minor administrative artifacts. Score of 0.93 reflects "strong traceability with minor administrative inconsistencies."

---

### Weighted Composite Calculation

```
Composite = (Completeness × 0.20) + (Internal Consistency × 0.20) + (Methodological Rigor × 0.20)
          + (Evidence Quality × 0.15) + (Actionability × 0.15) + (Traceability × 0.10)

= (0.94 × 0.20) + (0.92 × 0.20) + (0.93 × 0.20) + (0.92 × 0.15) + (0.95 × 0.15) + (0.93 × 0.10)

= 0.188 + 0.184 + 0.186 + 0.138 + 0.1425 + 0.093

= 0.9315

≈ 0.93
```

### Verdict

**Score: 0.93**
**Verdict: REVISE**
**C4 Threshold: 0.95 — FAILED**
**General Threshold (H-13): 0.92 — PASSED (0.93 > 0.92)**

**Special Conditions Check:**
- Any dimension <= 0.50 (Critical failure)? No — minimum dimension score is 0.92 (Internal Consistency and Evidence Quality)
- Any new Critical findings? No — all I3 findings are Major (2) or Minor (many)
- Prior Critical findings unresolved? No — all 3 I1 Criticals resolved in R2; confirmed in I3 review

**Improvement from I2:** Score improved from 0.90 to 0.93 (+0.03). All 10 P1-P10 priority fixes from I2 are RESOLVED. R3 has crossed the H-13 general threshold (0.92) for the first time. Gap to C4 threshold: 0.93 vs. 0.95 required. Gap = 0.02.

**Score Trajectory:** I1=0.83 → I2=0.90 → I3=0.93. Delta per iteration: +0.07, +0.03. Decelerating but not plateaued (delta > 0.01 for 3 consecutive, so no early halt trigger per RT-M-010).

### Dimension Scores Summary

| Dimension | Weight | I2 Score | I3 Score | Delta | Weighted I3 | Notes |
|-----------|--------|----------|----------|-------|-------------|-------|
| Completeness | 0.20 | 0.91 | 0.94 | +0.03 | 0.188 | All P1-P10 major completeness gaps addressed |
| Internal Consistency | 0.20 | 0.88 | 0.92 | +0.04 | 0.184 | 75/74 resolved; new minor Tier 3 enumeration gap |
| Methodological Rigor | 0.20 | 0.90 | 0.93 | +0.03 | 0.186 | SE-5 publication bias addresses key gap |
| Evidence Quality | 0.15 | 0.90 | 0.92 | +0.02 | 0.138 | C-3 403 issue and Tier 3 enumeration minor |
| Actionability | 0.15 | 0.93 | 0.95 | +0.02 | 0.1425 | Phase 2 design comprehensive with priority signals |
| Traceability | 0.10 | 0.90 | 0.93 | +0.03 | 0.093 | Group C fully enumerated; PS Entry ID artifact |
| **Composite** | **1.00** | **0.90** | **0.93** | **+0.03** | **0.9315** | Below C4 (0.95); above H-13 (0.92) |

### Leniency Bias Verification

- Each dimension scored independently: YES
- Evidence documented for each score in both directions: YES
- Uncertain scores resolved downward: YES (Internal Consistency: 0.92 not 0.93 due to Tier 3 count discrepancy; Evidence Quality: 0.92 not 0.93 due to C-3 inaccessible source and A-31 independence inflation)
- High-scoring dimensions (>= 0.93): Completeness (0.94), Methodological Rigor (0.93), Actionability (0.95), Traceability (0.93) — all justified by substantial documented improvements
- Low-scoring dimensions: Internal Consistency (0.92) — justified by Tier 3 count discrepancy, C-2 deduplication table inconsistency, DA-001-R3 parallel construction, PS Entry ID mismatch
- Weighted composite math: 0.188 + 0.184 + 0.186 + 0.138 + 0.1425 + 0.093 = 0.9315 ✓
- Verdict matches score: REVISE (0.93 < 0.95 C4 threshold) ✓

### Improvement Recommendations for I4 (Priority Order)

To close the 0.02 gap to C4 threshold (0.95), the following prioritized fixes are identified:

| Priority | ID(s) | Severity | Dimension Impact | Action |
|----------|--------|----------|-----------------|--------|
| **P1** | SR-001-R3, CC-001-R3, FM-014 | Major | Traceability +0.01, Internal Consistency +0.01 | Update PS Integration Entry ID from "Barrier-1-Synthesis-R2" to "Barrier-1-Synthesis-R3" |
| **P2** | CV-001-R3, FM-015 | Minor | Internal Consistency +0.01, Evidence Quality +0.01 | Reconcile Tier 3 count note: verify exact count (14 vs. 15); if 15, update header; if 14, remove one entry from the enumerated list (likely C-19 or A-31 was already counted elsewhere) |
| **P3** | SR-002-R3 | Minor | Internal Consistency +0.01, Traceability +0.01 | Correct Deduplication Decisions table to show C-2 as a separate entry distinct from the I-1/C-1 deduplication decision |
| **P4** | DA-001-R3, FM-016 | Major | Internal Consistency +0.01, Methodological Rigor +0.01 | Revise L0 epistemic distinction paragraph to avoid false-balance parallel construction; distinguish the 60% claim null finding from AGREE-4's directional findings |
| **P5** | SM-001-R3, SM-002-R3 | Minor | Completeness +0.01, Methodological Rigor +0.01 | (a) State the evidence basis for intra-subgroup ranking in AGREE-5 ranks 6-12 (or explicitly state the ranking is synthesizer judgment, not evidential); (b) Add Best Case Scenario paragraph to L0 |
| **P6** | CV-002-R3 | Minor | Evidence Quality +0.01 | Add explicit note to C-3 catalog entry and Source Count Verification: "C-3 was inaccessible at 403; key finding is inferred from URL and context7 survey description, not direct content retrieval. Include with caveat." |
| **P7** | IN-001-R3 | Minor | Completeness +0.01, Methodological Rigor +0.01 | Add explicit note to AGREE-4: "These aggregate failure rates may not generalize to expert prompt engineers using model-specific constraint design; user expertise as a moderating variable is not controlled in current evidence." |

**Estimated I4 achievable score if P1-P4 completed:** ~0.94 (approaches C4 threshold)
**Estimated I4 achievable score if P1-P7 completed:** ~0.95-0.96 (meets C4 threshold)

---

## Consolidated Findings Index

> New findings from Iteration 3 only. I2 findings that are RESOLVED are tracked in Prior Finding Resolution Status.

| ID | Strategy | Severity | Finding (one-line) | Section |
|----|----------|----------|--------------------|---------|
| SR-001-R3 | S-010 | Major | PS Integration Entry ID still reads "R2" for an R3 document — traceability/metadata discrepancy | PS Integration |
| SR-002-R3 | S-010 | Minor | Deduplication decisions table groups C-2 with I-1/C-1 despite C-2 correctly counted as distinct | Source Count Verification |
| SR-003-R3 | S-010 | Minor | Revision Log R3 entry does not address RT-004 (circular citation chain) status | Revision Log |
| SR-004-R3 | S-010 | Minor | AGREE-5 ranks 6-12 intra-subgroup ranking has no stated evidential basis | L1: AGREE-5 |
| SM-001-R3 | S-003 | Minor | AGREE-5 ranks 6-12 evidence basis unstated (persisting from I2) | L1: AGREE-5 |
| SM-002-R3 | S-003 | Minor | Best Case Scenario absent from synthesis body (persisting from I1/I2) | General / L0 |
| DA-001-R3 | S-002 | Major | L0 epistemic distinction paragraph's parallel construction creates false-balance framing | L0: Executive Summary |
| DA-002-R3 | S-002 | Minor | AGREE-4 cites A-31 (Tier 3 unreviewed) as evidence of "broader academic base" — overstates independence | L1: AGREE-4 |
| PM-001-R3 | S-004 | Minor | GAP-5 "DO NOT CITE" box follows the unverified figures rather than preceding them (persisting from I2) | L1: Gaps, GAP-5 |
| PM-002-R3 | S-004 | Minor | PS Entry ID R2/R3 mismatch creates version management risk (pre-mortem framing of SR-001-R3) | PS Integration |
| RT-001-R3 | S-001 | Minor | AGREE-4 includes A-31 (Tier 3 unreviewed) in "broader academic base" list without tier qualification | L1: AGREE-4 |
| RT-002-R3 | S-001 | Minor | CONFLICT-2 explanation (4) (pragmatic prohibition recognition) ranked "least testable" despite being most hypothesis-relevant | L1: CONFLICT-2 |
| CC-001-R3 | S-007 | Minor | P-022 minor: PS Integration Entry ID "R2" factual discrepancy in R3 document | PS Integration |
| CV-001-R3 | S-011 | Minor | Tier 3 count note lists 15 source IDs while header states 14 — arithmetic discrepancy in Evidence Tier Analysis | L1: Evidence Tier Analysis |
| CV-002-R3 | S-011 | Minor | C-3 (OpenAI platform docs, 403 inaccessible) counted as unique source; key finding is inferred, not verified | Group C catalog, C-3 entry |
| FM-014 | S-012 | Minor | FM RPN 150: PS Entry ID mismatch (R2/R3) creates orchestration routing risk | PS Integration |
| FM-015 | S-012 | Minor | FM RPN 80: Tier 3 count note lists 15 items, header states 14 — arithmetic artifact | Evidence Tier Analysis |
| FM-016 | S-012 | Minor | FM RPN 120: L0 parallel construction ambiguity may be read as false balance | L0 Epistemic Distinction |
| IN-001-R3 | S-013 | Minor | Expert user expertise as moderating variable not addressed in AGREE-4 or experimental design | L1: AGREE-4 |

**Total new I3 findings: 19** (2 Major, 17 Minor). No new Critical findings.

---

## Execution Statistics

- **Total new findings (I3):** 19
- **Critical:** 0
- **Major:** 2 (SR-001-R3 PS Entry ID, DA-001-R3 false balance framing)
- **Minor:** 17
- **Prior I2 Major Findings Resolved:** 10 of 14 (all P1-P10 fixes)
- **Prior I2 Minor Findings Resolved:** 8 of 14 (persisting minors: SM-002-R2, PM-003-R2, RT-003-R2, RT-004-R2, CC-002-R2, CV-003-R2)
- **Score delta:** 0.90 (I2) → 0.93 (I3) = +0.03 improvement
- **Protocol Steps Completed:** All 10 strategies fully executed (S-010 through S-014)
- **C4 Threshold Status:** FAILED (0.93 vs. 0.95 required); gap = 0.02
- **H-13 Threshold Status:** PASSED (0.93 > 0.92) — FIRST PASS of general threshold
- **Score trajectory:** I1=0.83, I2=0.90, I3=0.93 (deltas: +0.07, +0.03)

---

## Revision Priorities

> Priority ordering for I4 revision. Goal: close the 0.02 gap to C4 threshold (0.95).

| Priority | ID(s) | Severity | Dimension Impact | Action | Estimated Score Gain |
|----------|--------|----------|-----------------|--------|---------------------|
| **P1** | SR-001-R3, CC-001-R3, FM-014 | Major | Traceability, Internal Consistency | Update PS Integration Entry ID to "Barrier-1-Synthesis-R3" | +0.01 composite |
| **P2** | CV-001-R3, FM-015 | Minor | Internal Consistency, Evidence Quality | Reconcile Tier 3 count: recount actual Tier 3 sources; correct note to list exactly the count stated | +0.01 composite |
| **P3** | DA-001-R3, FM-016 | Major | Internal Consistency, Methodological Rigor | Revise L0 epistemic distinction: separate the null finding on the 60% claim from AGREE-4's directional findings; avoid parallel construction that implies evidentiary symmetry | +0.01 composite |
| **P4** | SR-002-R3 | Minor | Internal Consistency, Traceability | Correct Deduplication Decisions table: split C-2 from I-1/C-1 row | +0.005 composite |
| **P5** | SM-001-R3, SR-004-R3 | Minor | Methodological Rigor, Completeness | State evidence basis for AGREE-5 intra-subgroup rank ordering (ranks 6-12), or explicitly label it as synthesizer judgment | +0.005 composite |
| **P6** | CV-002-R3 | Minor | Evidence Quality | Add note to C-3 entry and Source Count Verification: "key finding inferred from survey description; inaccessible at 403" | +0.005 composite |
| **P7** | SM-002-R3 | Minor | Completeness | Add explicit Best Case Scenario paragraph to L0 or L1 synthesis body | +0.005 composite |
| **P8** | IN-001-R3 | Minor | Completeness, Methodological Rigor | Add note to AGREE-4: user expertise as a potential moderating variable; aggregate failure rates may not generalize to expert prompt engineers | +0.005 composite |
| **P9** | SR-003-R3, CV-003-R2 | Minor | Traceability | Update Revision Log to explicitly state RT-004 deferral status | +0.003 composite |
| **P10** | PM-001-R3 | Minor | Completeness | Move GAP-5 "DO NOT CITE" box to precede the unverified figures | +0.003 composite |

**Estimated I4 achievable score if P1-P3 completed:** ~0.94
**Estimated I4 achievable score if P1-P7 completed:** ~0.95 (meets C4 threshold)
**Estimated I4 achievable score if P1-P10 completed:** ~0.96

**Note:** The two Major findings (SR-001-R3 and DA-001-R3) are relatively narrow fixes — PS metadata update and a sentence-level L0 revision. Neither requires structural restructuring of the synthesis. The 0.02 gap to C4 is addressable in I4 with targeted text corrections.

---

*Findings produced by adv-executor | Iteration 3 | 2026-02-27*
*Constitutional Compliance: P-003 (no recursive subagents), P-020 (user authority respected), P-022 (all findings evidence-based; severity not minimized or inflated)*
*H-15 self-review applied: all findings verified against R3 synthesis content; severity classifications evidence-justified; finding identifiers use SR/SM/DA/PM/RT/CC/CV/FM/IN prefix format; summary table consistent with detailed findings*
*Leniency bias counteraction: scores at 0.93 composite (REVISE); all uncertain scores resolved downward; C4 threshold 0.95 not reached*
